Day 1 Morning: Vascular Access Masterclass Controversies - Tuesday, 23rd April
Venue: Theatre 3
Time: 08:00 - 13:00
Controversy 1: We don’t know what the right access, right time for the right patient is
Time: 08:00 - 09:10
| Anchor: | Nicholas Inston, Birmingham, United Kingdom |
| Moderator: | Kate Steiner, Stevenage, United Kingdom |
08:00 - 08:05
Updates from the Hamburg Registry
| Speaker: | Robert Shahverdyan, Hamburg, Germany |
08:05 - 08:10
Audience participation & discussion
08:10 - 08:15
Access registries are currently inadequate
| Speaker: | Maarten Snoeijs, Maastricht, Netherlands |
08:15 - 08:20
Audience participation & discussion
08:20 - 08:25
We are adding to renal patient workload burden unnecessarily
| Speaker: | Karen Stevenson, Glasgow, United Kingdom |
08:25 - 08:30
Audience participation & discussion
08:30 - 08:35
Fistulas in the elderly and frail are pointless
| Speaker: | Flavia Gentile Johansson, Strassen, Luxembourg |
08:35 - 08:40
Audience participation & discussion
08:40 - 08:45
Fistulas are not the best access! Grafts should be 1st
| Speaker: | David Kingsmore, Glasgow, United Kingdom |
08:45 - 08:50
Audience participation & discussion
08:50 - 08:55
Dynamic AVF is the answer
| Speaker: | Koen van der Bogt, Leiden and The Hague, Netherlands |
08:55 - 09:00
Audience participation & discussion
09:00 - 09:05
We don’t know which DCB to use next: The PAVE and PAVE-2 studies
| Speaker: | Michael Robson, London, United Kingdom |
09:05 - 09:10
Audience participation & discussion
Great Debate: Endovascular AVFs are a failed experiment
Time: 09:10 - 10:10
| Anchor: | Nicholas Inston, Birmingham, United Kingdom |
| Moderator: | Narayan Karunanithy, London, United Kingdom |
09:10 - 09:20
Secondary interventions make endovascular AVFs unrealistic
For the motion
09:10 - 09:20
| Tobias Steinke, Dusseldorf, Germany |
09:20 - 09:30
Endovascular AVFs are part of the algorithm
Against the motion
09:20 - 09:30
| Robert Shahverdyan, Hamburg, Germany |
09:30 - 09:40
We can achieve better results with surgical AVFs
For the motion
09:30 - 09:40
| Shannon Thomas, Sydney, Australia |
09:40 - 09:50
Endovascular AVFs already are standard of care and need to be in the guidelines
Against the motion
09:40 - 09:50
| Monnie Wasse, Chicago, United States |
09:50 - 10:10
Audience participation, discussion & voting
Coffee break
Time: 10:10 - 10:30
Real cases, real problems
Time: 10:30 - 11:00
| Chairing: | Nicholas Inston, Birmingham, United Kingdom |
10:30 - 11:00
A short multidisciplinary team (MDT) meeting-style session to review new cases and clinical conundrums. This is a discussion-led session and will pose questions and polls to the audience.
Controversy 2: We have new technology but do we need it?
Time: 11:00 - 13:00
| Anchor: | Kate Steiner, Stevenage, United Kingdom |
| Moderator: | Narayan Karunanithy, London, United Kingdom |
11:00 - 11:05
Revolutionising haemodialysis access: Unveiling the latest advancements from the aXess trials
| Speaker: | Robert Shahverdyan, Hamburg, Germany |
11:05 - 11:10
Audience participation & discussion
11:10 - 11:15
EU registry AV Arm
| Speaker: | Matteo Tozzi, Varese, Italy |
11:15 - 11:20
Audience participation & discussion
11:20 - 11:25
Do we need more stents?
| Speaker: | Robert Jones, Birmingham, United Kingdom |
11:25 - 11:30
Audience participation & discussion
11:30 - 11:35
A multicenter analysis of the treatment of AVF/AVG of 114 patients with a flexible self-expanding endograft
| Speaker: | Leonardo Harduin, Niteroi, Brazil |
11:35 - 11:40
Audience participation & discussion
11:40 - 11:45
Next generation endovascular AVF devices are required
| Speaker: | Robert Shahverdyan, Hamburg, Germany |
11:45 - 11:50
Audience participation & discussion
11:50 - 11:55
External support in surgical fistulas: A standard of care?
| Speaker: | Ellen Dillavou, Chapel Hill, United States |
11:55 - 12:00
Audience participation & discussion
12:00 - 12:05
Fistula creation: Functional independence measure results
| Speaker: | Nicholas Inston, Birmingham, United Kingdom |
12:05 - 12:10
Audience participation & discussion
12:10 - 12:15
Vein dilatation system
| Speaker: | Surendra Shenoy, St Louis, United States |
12:15 - 12:20
Audience participation & discussion
12:20 - 12:25
We know what DCB to use! ABISS trial
| Speaker: | Raphael Coscas, Paris, France |
12:25 - 12:30
Audience participation & discussion
12:30 - 12:35
Podium First: IN.PACT AV Access outcomes. We know which DCB to use!
| Speaker: | Andrew Holden, Auckland, New Zealand |
12:35 - 12:40
Audience participation & discussion
12:40 - 13:00
Panel discussion
Lunch break
Time: 13:00 - 13:30
Day 1 Afternoon: Renal Interventions Controversies
Venue: Theatre 3
Time: 13:00 - 18:00
Sponsored Education
Time: 13:30 - 14:00
Controversy 3: We have all the tools, we just don’t use them properly
Time: 14:00 - 15:50
| Anchor: | Robert Shahverdyan, Hamburg, Germany |
| Moderator: | Karen Stevenson, Glasgow, United Kingdom |
14:00 - 14:05
Real-time monitoring of vascular access
| Speaker: | Rajesh Sivaprakasam, London, United Kingdom |
14:05 - 14:10
Audience participation & discussion
14:10 - 14:15
Surveillance: We have the tools, we don’t use them properly
| Speaker: | David Kingsmore, Glasgow, United Kingdom |
14:15 - 14:20
Audience participation & discussion
14:20 - 14:30
Panel discussion
14:30 - 14:35
Leg access options are underused
| Speaker: | Karen Stevenson, Glasgow, United Kingdom |
14:35 - 14:40
Audience participation & discussion
14:40 - 14:45
Post-procedure volume flow measurement: Proving rather than assuming success
| Speaker: | Panagiotis Kitrou, Patras, Greece |
14:45 - 14:50
Audience participation & discussion
14:50 - 15:50
Roundtable: The international approach to vascular access problems
| Moderator: | Nicholas Inston, Birmingham, United Kingdom |
| Panel: | Robert Shahverdyan, Hamburg, Germany |
| Robert Jones, Birmingham, United Kingdom | |
| Shannon Thomas, Sydney, Australia | |
| Raphael Coscas, Paris, France | |
| Maarten Snoeijs, Maastricht, Netherlands |
Tea break
Time: 15:50 - 16:10
Real cases, real problems
Time: 16:10 - 16:40
| Chairing: | Kate Steiner, Stevenage, United Kingdom |
16:10 - 16:40
A short multidisciplinary team (MDT) meeting-style session to review interventional radiology cases and clinical conundrums. This is a discussion-led session and will pose questions and polls to the audience.
| Faculty: | Robert Jones, Birmingham, United Kingdom |
| Narayan Karunanithy, London, United Kingdom |
Renal interventions session: Controversies in renal vessel management
Time: 16:40 - 18:00
| Anchor: | Nicholas Inston, Birmingham, United Kingdom |
| Moderator: | Frank Dor, London, United Kingdom |
16:40 - 16:45
There is a role for renal denervation
| Speaker: | Neelan Das, London, United Kingdom |
16:45 - 16:50
Renal artery denervation has resurfaced! Why vascular surgeons and interventional radiologists should care
| Speaker: | Lindsay Machan, Vancouver, Canada |
16:50 - 17:00
Audience participation & discussion
17:00 - 17:05
Nutcracker syndrome: Is it real?
| Speaker: | Paul Crowe, Birmingham, United Kingdom |
17:05 - 17:10
Nutcracker syndrome: Therapeutic approaches
| Speaker: | James Barnes, Birmingham, United Kingdom |
17:10 - 17:15
Surgery is the best option for nutcracker syndrome
| Speaker: | Frank Dor, London, United Kingdom |
17:15 - 17:30
Audience participation & discussion
17:30 - 17:35
Fibromuscular Dysplasia (FMD) needs a defined approach
| Speaker: | Robert Jones, Birmingham, United Kingdom |
17:35 - 17:40
Audience participation & discussion
17:40 - 17:50
Renal artery aneurysms need a defined approach
| Speaker: | Robert Morgan, London, United Kingdom |
17:50 - 18:00
Audience participation & discussion